S272: SAFETY AND PRELIMINARY PHARMACODYNAMIC EFFECTS OF THE FERROPORTIN INHIBITOR VAMIFEPORT (VIT-2763) IN PATIENTS WITH NON-TRANSFUSION-DEPENDENT BETA THALASSEMIA (NTDT): RESULTS FROM A PHASE 2A STUDY

Authors: A. Taher, A. Kourakli-Symeonidis, A. Tantiworawit, P. Wong, P. Szecsödy

Published: 2022-06-23

DOI: 10.1097/01.hs9.0000843980.18213.bf

Source: Full article

---

Abstract

No abstract found.